维普中文期刊产品整合服务
837篇 您的检索式:作者名="BELL A M"
    题名 作者 年代 出处 被引量
1Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience显示文摘AIM To evaluate the long-term treatment outcomes of tenofovir therapy in patients in a real world Australian tertiary care setting.METHODS We performed a retrospective analysis of treatment outcomes among treatment-na?ve and treatment-experienced patients receiving a minimum 3 mo tenofovir therapy through St Vincent's Hospital Melbourne, Australia. We included patients receiving tenofovir [tenofovir disoproxil fumarate(TDF)] monotherapy, as well as patients treated with TDF in combination with a second antiviral agent. Patients were excluded if they demonstrated human immune-deficiency virus/hepatitis C virus/hepatitis delta virus coinfection or were less than 18 years of age. We considered virological and biochemicalresponse, as well as safety outcomes. Virological response was determined by measurement of hepatitis B virus(HBV) DNA using sensitive assays; biochemical response was determined via serum liver function tests; histological response was determined from liver biopsy and fibroscan; safety analysis focused on glomerular renal function and bone mineral density. The primary efficacy endpoint was complete virological suppression over time, defined by HBV DNA < 20 IU/m L. Secondary efficacy endpoints included rates of biochemical response, and HB e antigen(HBe Ag)/HB surface antigen loss and seroconversion over time.RESULTS Ninety-two patients were identified who fulfilled the enrolment criteria. Median follow-up was 26 mo(range 3-114). Mean age was 46(24-78) years, 64(70%) were male and 77(84%) were of Asian origin. 55(60%) patients were treatment-na?ve and 62 patients(67%) were HBe Ag-negative. Complete virological suppression was achieved by 45/65(71%) patients at 12 mo, 37/46(80%) at 24 mo and 25/28(89%) at 36 mo. Partial virological response(HBV DNA 20-2000 IU/m L) was achieved by 89/92(96.7%) of patients. Multivariate analysis showed a significant relationship between virological suppression at end of follow-up and baseline HBV DNA level(OR = 0.897, 95%CI: 0.833-0.967, P = 0.0046) and HBe Ag positive status(OR = 0.373, 95%CI: 0.183-0.762, P = 0.0069). There was no difference in response comparing treatment-na?ve and treatment-experienced patients. Three episodes of virological breakthrough occurred in the setting of noncompliance. Tenofovir therapy was well tolerated.CONCLUSION Tenofovir is an efficacious, safe and well-tolerated treatment in an Australian real-world tertiary care setting. Our data are similar to the reported experience from registration trials.Grace C Lovett Tin Nguyen David M Iser Jacinta A Holmes Robert Chen Barbara Demediuk Gideon Shaw Sally J Bell Paul V Desmond Alexander J Thompson 2017World Journal of Hepatology2017,9,1:7
2Infectious hypodermal and hematopoietic necrosis, a newly recognized virus disease of penaeid shrimp显示文摘Lightner D V Redman R M Bell T A 1983Invertebrate Pathology1983,42,:2
3The effect of the stre ngth properties of wool staples on worsted processing,Part Ⅰ:The level of staple strength 显示文摘Rottenbury R A Andrews M W Bell P J M 1986J Text Inst1986,,77:2
4Optical properties of the metals Al, Co, Cu, Au, Fe, Pb, Ni, Pd, Pt, Ag, Ti, and W in the infrared and far infrared 显示文摘Ordal M A Long L L Bell R J 1983Applied Optics1983,22,7:2
5IL 28 B genotype is not useful for predicting treatment outcome in A sian chronic hepatitis B patients treated with pegylated interferon‐α显示文摘Jacinta A Holmes Tin Nguyen Dilip Ratnam Neel M Heerasing Jane V Tehan Sara Bonanzinga Anouk Dev Sally Bell Stephen Pianko Robert Chen Kumar Visvanathan Rachel Hammond David Iser Ferry Rusli William Sievert Paul V Desmond D Scott Bowden Alexander J Thomps 2013J Gastroenterol Hepatol2013,,5:2
6A annotated checklist of the mosses of Europe and Macaronesia 显示文摘Hill M O Bell N Bruggeman-Nannenga M A 2006Journal of Bryology2006,28,:1
7Synthesis and characterization of polypyrrole-magnetite-silica particles显示文摘Btterworth M D Bell S A Armes S P Simpson A W 1996J Colloid Interf Sci1996,183,:1
8Analysis of fMRI data by blind separation into independent spatial components 显示文摘Mckeown M J Makelg S Brown G G Jung T P Kinderman S S Bell A J and Sejnowski T J 1998Human Brain Mapping1998,6,:1
9A physicochemical study of the aging of colloidal sillica gels used in zeolite Y synthesis显示文摘Ginter D M Went G T Bell A T 1992Zeolites1992,12,:1
10Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins显示文摘Jantzen H M Admon A Bell S P 1990Nature1990,344,:1
11Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle显示文摘BELL S P SACK M N PATEL A 2000J Am Coll Cardiol2000,36,7:1
12Peritoneal implants of o- varian serous borderline tumors: histologie features and prognosis 显示文摘Bell D A Weinstock M A Scully R E 1988Cancer1988,62,10:1
13Depression biases the recognition of emotionally neutral faces显示文摘Lepp(a)nen JM Milders M Bell JS 2004Psychiat Res2004,128,2:1
14Planning the use of fish for food security in the Pacific显示文摘Bell J D Kronen M Vunisea A 2009Marine Policy2009,,:1
15NF-κB is activated during acute inflammation in vivo in association with molecule gene expression and leukocyte recruitment显示文摘 BELL F P ROSENBLOOM J G 1995J Inflamm1995,45,4:1
16Weight gain and its predictors in Chinese adults 显示文摘BELL A C GE K POPKIN B M 2001Int J Obsity2001,25,:1
17Effect of Safflower Oil, Flaxseed Oil, Monensin, and Vitamin E on Concentration of Conjugated Linoleic Acid in Bovine Milk Fat 显示文摘BELL J A GRIINARI J M KENNELLY J j 2006J Dairy Sci2006,89,2:1
18Functions of sphingolipids and sphingolipid breakdown products in cellular regulation显示文摘HANNUN Y A BELL R M 1989Science1989,243,4890:1
19Increased brain edema in aqp4-null mice in an experimental model of subarachnoid hemorrhage显示文摘TAIT M J SAADOUN S BELL B A etal 2010Neuroscience2010,167,1:1
20Technology Spillovers from Foreign Direct Investment FDI:An Exploration of the Active Role of MNC Subsidiaries in the Case of Argentina in the 1990s' 显示文摘MARIN A M BELL 2006Journal of Development Studies2006,,42:1
返回顶部 每页显示:
共42页 首页 上一页 第1页 下一页 末页 /42 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费